The Use of Hyaluronidase in Orofacial Harmonization – Narrative Review
DOI:
https://doi.org/10.33448/rsd-v11i5.28119Keywords:
Hyaluronic Acid; Adverse effects; Hypersensitivity.Abstract
Hyaluronidase is an enzyme responsible for the degradation of hyaluronic acid, which, when applied in a way that generates adverse effects, must be used. The objective of this article was to carry out a narrative review of the literature on the use of hyaluronidase in orofacial harmonization, to present its indications, contraindications, as well as its level of effectiveness. Searches were carried out in scientific databases (PubMed and Google Scholar) and included literature reviews, case reports and clinical studies published between 2016 and 2021, in English and Portuguese. It was concluded that, within the scope of orofacial harmonization, hyaluronidase is indicated for the management of complications related to hyaluronic acid fillers. It is effective in the management of mild or severe complications, and can be applied in the treatment of hematomas, nodules, granulomas, foreign body reactions and inflammatory reactions, as well as for vascular complications such as tissue necrosis and livedo reticularis. Its use is contraindicated in case of hypersensitivity to its components. Side effects caused by hyaluronidase are rare and involve allergic reaction and local itching.
References
Beleznay, K. Carruthers, J. D. A. Humphrey, S. Carruthers, A. & Jones, D. (2019). Update on Avoiding and Treating Blindness From Fillers: A Recent Review of the World Literature. Aesthet Surg J. 16;39(6):662-674.
Weber, G. C. Buhren, B. A. Buhren, B. A. Schrumpf, H. Hoff, N. P. Bölke, E. Hilton, S. & Gerber, P. A. (2016). Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res. 13;21:5.
Goodman, G. J. Liew, S. Callan, P. & Hart, S. (2020). Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 61(3):217-225.
Lee, W. Hwang, S. Oh, W. et al. (2020). Practical Guidelines for Hyaluronic Acid Soft-Tissue Filler Use in Facial Rejuvenation. Dermatol Surg. 46(1):41-49.
Mccann, M. (2019). Intravenous Hyaluronidase for Visual Loss Secondary to Filler Injection: A Novel Therapeutic Approach. J Clin Aesthet Dermatol. 12(12):25-27.
Neto, S. J. M. A. Calado, J. L. T. Melo, M. H. A. S. et al. (2020). Hialuronidase: uma necessidade de todo cirurgião dentista que aplica ácido hialurônico injetável. REAS/EJCH, 39, e. 2296.
Rocha, R. C. C. Castilho, L. B. Blaas, D. M. A. Tavares Júnior, R. Tavares, A. P. & Wanczinski, M. I. (2018). A importância do uso precoce de hialuronidase no tratamento de oclusão arterial por preenchimento de ácido hialurônico. Surg Cosmet Dermatol. 10(1):77-9.
Sito, G. Manzoni, V. & Sommariva, R. (2019). Vascular Complications after Facial Filler Injection: A Literature Review and Meta-analysis. J Clin Aesthet Dermatol. 12(6):E65-E72.
Urdiales-Gálvez, F. Delgado, N. E. Figueiredo, V. Lajo-Plaza, J. V. Mira, M. Moreno, A. et al. (2018). Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plast Surg. 42(2):498-510.
Vasconcelos, S. C. B. Nascente, F. M. Souza, C. M. D. et al. (2020). O uso do ácido hialurônico no rejuvenescimento facial. Revista Brasileira Militar de Ciencias. v. 6, n. 14.
Wollina, U. & Goldman, A. (2020). Facial vascular danger zones for filler injections. Dermatol Ther. 33(6):e14285.
Zhu, J. Tang, X. Jia, Y. Ho, C. T. & Huang, Q. (2020). Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery - A review. Int J Pharm. 30;578:119127.
Chauhan, A. & Singh, S. (2019). Management of Delayed Skin Necrosis Following Hyaluronic Acid Filler Injection Using Pulsed Hyaluronidase. J Cutan Aesthet Surg. 12(3):183-186.
Baley-Spindel, I. Villaseñor-Villalpando, E. Márquez-Espriella, C. Rivera-Salgado, M. I. & Dávila-Díaz, R. (2020). Perivascular Hyaluronidase With Alteplase as Treatment for Hyaluronic Acid Thrombosis. Aesthet Surg J. 14;40(5):551-559.
Paap, M. K. Milman, T. Ugradar, S. Goldberg, R. & Silkiss, R. Z. (2020). Examining the Role of Retrobulbar Hyaluronidase in Reversing Filler-Induced Blindness: A Systematic Review. Ophthalmic Plast Reconstr Surg. 36(3):231-238.
Weber, G. C. Buhren, B. A. Schrumpf, H. Wohlrab, J. & Gerber, P. A. (2019). Clinical Applications of Hyaluronidase. Adv Exp Med Biol. 1148:255-277.
Zhang-Nunes, S. Ryu, C. Cahill, K. Straka, D. Nabavi, C. Czyz, C. & Foster, J. (2021). Prospective in vivo evaluation of three different hyaluronic acid gels to varying doses of hyaluronidase with long-term follow-up. J Plast Reconstr Aesthet Surg. 74(4):874-880.
Ryu, C. Lu, J. E. Zhang-Nunes, S. (2021). Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase. J Plast Reconstr Aesthet Surg. 74(4):881-889.
Rauso, R. Zerbinati, N. Franco, R. Chirico, F. Ronchi, A. Sesenna, E. Colella, G. & Tartaro, G. (2020). Cross-linked hyaluronic acid filler hydrolysis with hyaluronidase: Different settings to reproduce different clinical scenarios. Dermatol Ther. 33(2):e13269.
Ors, S. (2020). The Effect of Hyaluronidase on Depth of Necrosis in Hyaluronic Acid Filling-Related Skin Complications. Aesthetic Plast Surg. 44(5):1778-1785.
Lee, W. Oh, W. Oh, S. M. & Yang, E. J. (2020). Comparative Effectiveness of Different Interventions of Perivascular Hyaluronidase. Plast Reconstr Surg. 145(4):957-964.
Santaella-Sosa, E. R. (2020). Outstanding efficacy of bacterial recombinant hyaluronidase concerning a subaccute filler complication clinical case. Dermatol Ther. 33(4):e 13726.
Diwan, Z. Trikha, S. Etemad-Shahidi, S. Virmani, S. Denning, C. Al-Mukhtar, Y. et al. (2020). Case Series and Review on Managing Abscesses Secondary to Hyaluronic Acid Soft Tissue Fillers with Recommended Management Guidelines. J Clin Aesthet Dermatol. 13(11):37-43.
Zhang, L. Luo, Z. Li, J. Liu, Z. Xu, H. Wu, M. & Wu, S. (2021). Endovascular Hyaluronidase Application Through Superselective Angiography to Rescue Blindness Caused by Hyaluronic Acid Injection. Aesthet Surg J. 41(3):344-355.
Munavalli, G. G. Guthridge, R. Knutsen-Larson, S. Brodsky, A. Matthew, E. & Landau, M. (2021). "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment". Arch Dermatol Res. 9:1–15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marco Aurélio Mena; Glaucia Cristina Pelegrini Mena; Daniella Pilon Muknicka; Roberto Teruo Suguihara; Angelica Castro Pimentel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
